“Second-Generation Androgen Receptor Inhibitors in Therapy of Non-Metastatic Castration Resistant Prostate Cancer: Role of Safety Profile and Effect on Quality of Life”. 2022. Voprosy Onkologii 67 (2): 217-26. https://doi.org/10.37469/0507-3758-2021-67-2-217-226.